TrialESMO open2023

S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma-final results of the randomized AIO MATEO phase II trial.

G Stocker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.